US Patent Issued to Gambro Lundia on Oct. 21 for "Apparatus for extracorporeal treatment of blood and method for determining a parameter indicative of the progress of an extracorporeal blood treatment" (Italian Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,248, issued on Oct. 21, was assigned to Gambro Lundia AB (Lund, Sweden).

"Apparatus for extracorporeal treatment of blood and method for determining a parameter indicative of the progress of an extracorporeal blood treatment" was invented by Paolo Rovatti (Modena, Italy) and Marco Salsa (Modena, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "An apparatus for extracorporeal treatment of blood (1) comprising a treatment unit, a blood withdrawal line, a blood return line, a preparation line and a spent dialysate line. A control unit (10) is configured to calculate values of a parameter relating to treatment effectiveness based on measures of the ...